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Editors’ NotesBehind the Scenes with Reprogramming
As the reprogramming field moves forward, researchers are looking more closely at the underlying mechanisms, because current
methods can be inefficient and some studies have suggested that the pluripotency of iPSCs is not entirely equivalent to that of
ESCs. In this issue, Jaenisch and colleagues show that subtle differences in the expression level and stoichiometry of reprogramming
factors can influence theepigenetic andpluripotent stateof iPSCs, suggesting that some instancesof incomplete reprogrammingmay
represent technical variation rather than a true biological limitation of these induced cells. Previous studies showed that vitamin C canenhance the reprogramming process, and Pei and colleagues
now delve into the mechanisms involved in that effect. They
show that vitamin C signaling activates the histone demethylases
Jhdm1a/1b, which induce demethylation at H3K36me2/3. The
authors identify two sites at which this demethylation occurs,
but further exploration of this histone mark could yield additional
insight into the mechanisms behind reprogramming. Also in this
issue, Wernig and colleagues review exciting recent advances
in producing induced neuronal cells and Thomas Graf provides
a historical account of the reprogramming field, with a focus on
how a wide array of evolving concepts and technologies laid
the foundation for the groundbreaking work seen in recent years.The Path of Differentiation
One key aspect in the functional utility of both embryonic and adult stem cells is in understanding their lineage and how to drive differ-
entiation of specific cell types. The heart, in particular, has yielded conflicting findings regarding the existence of an adult cardiac
stem cell population and its potential for regenerating cardiac cell types. Here, Harvey and colleagues identify a population of mesen-
chymal-stem-cell-like cardiac progenitor cells in developing and adult mice with broad trans-germ layer potential in vitro and in vivo
(see also the Preview by Slukvin). The full range of lineage
descendents remains to be studied, but the finding has inter-
esting implications for the potential regenerative capabilities of
cardiac tissue. In a paper examining the lineage of stem cell
populations in the zebrafish retina, Wittbrodt and colleagues
show that the two tissues of the retina—neural retina and
retinal-pigmented epithelium—are maintained by two separate
populations of fate-restricted stem cells that are generated
from a multipotent neural stem cell. The two stem cell popula-
tions allow coordinated growth of the retina, and the mecha-
nisms underlying such coordination will be an interesting area
of future study. Understanding the lineage of hematopoietic
stem cells (HSCs) is crucial for their production from pluripotent
cells, and a new paper from Speck and colleagues unravels the relationship between HSCs and erythroid-myeloid progenitors
(EMPs), both of which develop from hemogenic endothelial precursors but are functionally quite different. The authors show thatwhile both populations require Runx1 and its non-DNA binding
subunit CBFb for their differentiation, they have specific temporal
and spatial requirements for CBFb and, as such, HSCs and EMPs
develop in distinct developmental time windows.
New Leaps and Hurdles in ESC
Technology
Embryonic stem cells are powerful tools for many approaches, but
their diploid nature presents challenges for genetic screens and
functional genomics. To overcome this problem, Penninger and
colleagues have generated haploidmouse ESC lines frompartheno-
genetic embryos (see also the Preview by Schimenti). The haploid
cells can differentiate into cells from all three germ layers in vitro
and in vivo and can be mutated to facilitate our study of recessive
mutations and disease phenotypes in various lineages. Combining
the power of functional genomics with the pluripotency of stem
cells promises exciting future discoveries from such cells. Human
ESCs, however, received more of a setback recently in the form of
the European Court of Justice prohibiting patents on hESC-based
inventions. In this issue, a series of Letters offers perspectives on
the ruling and its potential impact on the stem cell field (see Letters
from Wilmut, Trounson and colleagues, Scott and colleagues, and
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